Profil
Alexander Zehnder currently works at CureVac NV, as Chief Executive Officer from 2023.
Dr. Zehnder also formerly worked at Avastin, as VP-Global Product Strategy & Global Franchise and Roche Holding AG, as Vice President.
Dr. Zehnder received his doctorate degree from the University of Bern and Masters Business Admin degree from International Institute for Management Development.
Postes actifs de Alexander Zehnder
| Sociétés | Poste | Début |
|---|---|---|
| CUREVAC | Directeur Général | 28/03/2023 |
Anciens postes connus de Alexander Zehnder
| Sociétés | Poste | Fin |
|---|---|---|
Avastin | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Formation de Alexander Zehnder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
University of Bern
University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avastin | |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
















